|
ZNF498 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.15190000047083E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.234880E-04 |
| Normal-vs-Stage2 |
6.522100E-02 |
| Normal-vs-Stage3 |
4.091600E-01 |
| Normal-vs-Stage4 |
8.314400E-01 |
| Stage1-vs-Stage2 |
6.866600E-01 |
| Stage1-vs-Stage3 |
2.117800E-01 |
| Stage1-vs-Stage4 |
2.817400E-01 |
| Stage2-vs-Stage3 |
2.099000E-01 |
| Stage2-vs-Stage4 |
2.543200E-01 |
| Stage3-vs-Stage4 |
7.651200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.53029999999865E-06 |
| Normal-vs-AfricanAmerican |
9.697800E-03 |
| Normal-vs-Asian |
9.533600E-01 |
| Caucasian-vs-AfricanAmerican |
8.031000E-01 |
| Caucasian-vs-Asian |
3.211800E-01 |
| AfricanAmerican-vs-Asian |
3.664400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.09190000002957E-06 |
| Normal-vs-Female |
2.142600E-03 |
| Male-vs-Female |
8.055400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.341900E-02 |
| Normal-vs-Extreme_Weight |
3.137400E-03 |
| Normal-vs-Obese |
1.784850E-03 |
| Normal-vs-Extreme_Obese |
5.078800E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.764200E-01 |
| Normal_Weight-vs-Obese |
4.996400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.929400E-01 |
| Extreme_Weight-vs-Obese |
9.318200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.048400E-01 |
| Obese-vs-Extreme_Obese |
4.105800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.745600E-02 |
| Normal-vs-Age(41-60Yrs) |
6.11970000008455E-07 |
| Normal-vs-Age(61-80Yrs) |
4.876700E-03 |
| Normal-vs-Age(81-100Yrs) |
4.267400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.260000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.614000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.651000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.494000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.683800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.470600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.61226629006251E-12 |
| Normal-VS-Type2 PRCC |
1.724610E-01 |
| Normal-VS-KIRP CIMP |
9.531800E-02 |
| Normal-VS-Unclassified PRCC |
3.298500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.94873023168429E-12 |
| Type1 PRCC-VS-KIRP CIMP |
2.1618000000112E-06 |
| Type1 PRCC-VS-Unclassified PRCC |
8.712300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.853600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.442200E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
7.758800E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.978000E-01 |
| Normal-vs-N1 |
5.208200E-01 |
| Normal-vs-N2 |
1.748230E-01 |
| N0-vs-N1 |
8.155600E-01 |
| N0-vs-N2 |
2.491600E-02 |
| N1-vs-N2 |
6.267600E-02 |
|
|
